FOXM1 and cancer: In this scenario, the primary mechanism of action of WIN site inhibitors is the eviction of WDR5 and MYC from chromatin and select RPG suppression, and the ultimate cellular outcome is governed by whether and how cancer cells respond to what is a fairly modest decline in their ribosomal protein inventory.